Ferric carboxymaltose comparable to oral iron supplementation for pregnant women with anemia
1. Although anemia prevalence at 36 weeks was slightly lower in the ferric carboxymaltose group compared to standard-of-care, statistical significance was not achieved. 2. Adverse events between both groups were comparable; there were no changes in birth weight. Evidence Rating Level: 1 (Excellent) Study Rundown: Anemia affects more than one-third of all pregnancies in Africa.
Source: 2minutemedicine.com